+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Autoinjectors: Global Markets 2021-2026

  • ID: 5480325
  • Report
  • November 2021
  • Region: Global
  • 123 Pages
  • BCC Research
UP TO OFF until May 31st 2022

FEATURED COMPANIES

  • Abbvie Inc.
  • Amgen Inc.
  • Antares Pharma Inc.
  • Becton, Dickinson and Co.
  • Eli Lilly And Co.
  • GlaxoSmithKline Plc

The global market for autoinjectors should grow from $41.5 billion in 2021 to $85.2 billion by 2026, at a compound annual growth rate (CAGR) of 15.5% for the period of 2021-2026. 




The North American market for autoinjectors should grow from $15.1 billion in 2021 to $28.4 billion by 2026, at a CAGR of 13.4% for the period of 2021-2026. 


The Asia-Pacific market for autoinjectors should grow from $10.2 billion in 2021 to $22.6 billion by 2026, at a CAGR of 17.2% for the period of 2021-2026.


Report Scope

This report examines the current market and projected market potential for autoinjectors. It offers a detailed analysis of the competitive environment, market background, technology, drivers and restraints, and market growth trends. The report also includes market projections to 2026 and rankings for key market players. The report segments the market for autoinjectors based on the type of product, route of administration, therapy, end user and geography or region.


The market by type of product is further segmented into disposable and reusable autoinjectors. The market by route of administration is further segmented into intramuscular and subcutaneous. The market by therapy is further segmented into anaphylaxis, rheumatoid arthritis, multiple sclerosis, diabetes, and others. The market by end-user is further segmented into home care settings, hospitals and clinics, and ambulatory care settings.


The market by region is segmented into North America, Europe, the Asia-Pacific region, and the Rest of the World. Analyses of major countries are covered in the report. For market estimates, data is provided for 2020 as the base year, 2021 and forecast through year-end 2026. Estimated values used are based on autoinjector manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.


The Report Includes

  • 41 data tables and 25 additional tables
  • Detailed review of the global market for autoinjectors within the medical devices industry
  • Analyses of the global market trends, with data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Evaluation and forecast the overall autoinjectors market size in dollar value term, and corresponding market share analysis by product type, route of administration, therapy, end-user, and region
  • Discussion of key market dynamics (DROs), technology advancements, regulatory scenario, pricing analysis, and competitive environment of the vendor companies
  • Country specific data and market value analysis for the U.S., Canada, U.K., France, Germany, Italy, Spain, Japan, China and India
  • Insight into the recent industry strategies, key M&A deals, company competitive landscape and value share analysis of the key players operating in the global autoinjectors market
  • Highlights of the market potential for autoinjectors, opportunities and gaps estimating current and future demand, and impact of COVID-19 on the progress of this market
  • Discussion of competitive intensity among the leading market participants, their global rankings and recent developments in the autoinjector market
  • Company profile descriptions of the leading manufacturers and suppliers of autoinjector devices including AbbVie Inc., Amgen Inc., Becton, Dickinson and Co., Eli Lilly, GlaxoSmithKline PLC, Johnson & Johnson, Merck KGaA, and Teva Pharmaceutical
Frequently Asked Questions about the Global Autoinjectors Market

What is the estimated value of the Global Autoinjectors Market?

The Global Autoinjectors Market was estimated to be valued at $41.5 Billion in 2021.

What is the growth rate of the Global Autoinjectors Market?

The growth rate of the Global Autoinjectors Market is 15.5%, with an estimated value of $85.2 Billion by 2026.

What is the forecasted size of the Global Autoinjectors Market?

The Global Autoinjectors Market is estimated to be worth $85.2 Billion by 2026.

Who are the key companies in the Global Autoinjectors Market?

Key companies in the Global Autoinjectors Market include Abbvie Inc., Amgen Inc., Antares Pharma Inc., Becton, Dickinson and Co., Eli Lilly And Co., GlaxoSmithKline Plc, Johnson & Johnson, Merck Kgaa and Teva Pharmaceutical Industries Ltd..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbvie Inc.
  • Amgen Inc.
  • Antares Pharma Inc.
  • Becton, Dickinson and Co.
  • Eli Lilly And Co.
  • GlaxoSmithKline Plc

Chapter 1 Introduction
  • Study Goals and Objectives
  • Reasons for Doing this Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Reports


Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
  • Introduction
  • Market Evolution


Chapter 4 Impact of COVID-19 Pandemic
  • Impact of COVID-19 on Markets
  • Changes in Consumption Trends for Health-Related Products


Chapter 5 Market Dynamics
  • Overview
  • Rising Incidence of Anaphylaxis
  • Growing Prevalence of Targeted Therapies
  • Market Restraints
  • Presence of Alternate Drug Delivery Routes
  • Stringent Regulatory Scenario


Chapter 6 Market Breakdown by Product Type
  • Market for Autoinjectors by Product Type
  • Disposable Autoinjectors
  • Market Size and Forecast
  • Reusable Autoinjectors
  • Market Size and Forecast


Chapter 7 Market Breakdown by Route of Administration
  • Market for Autoinjectors by Route of Administration
  • Intramuscular
  • Market Size and Forecast
  • Subcutaneous
  • Market Size and Forecast


Chapter 8 Market Breakdown by Therapy
  • Anaphylaxis
  • Market Size and Forecast
  • Rheumatoid Arthritis
  • Market Size and Forecast
  • Multiple Sclerosis
  • Market Size and Forecast
  • Diabetes
  • Market Size and Forecast
  • Others
  • Market Size and Forecast


Chapter 9 Market Breakdown by End User
  • Home Care Settings
  • Market Size and Forecast
  • Hospitals and Clinics
  • Market Size and Forecast
  • Ambulatory Care Settings
  • Market Size and Forecast


Chapter 10 Market Breakdown by Region
  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
  • Latin America
  • Middle East and Africa


Chapter 11 Regulatory Scenarios
  • Medical Device Definition and Classification
  • Regulations in the U.S.
  • Code of Federal Regulations
  • Electronic Code of Federal Regulations
  • Premarket Notification 510(k) Clearance to Market
  • 510(k) Exempt Devices
  • Pre-Market Approval
  • European Regulations
  • Regulation in North American Countries
  • U.S. Regulations
  • Canadian Regulations
  • Regulation in Latin America
  • Regulation in Asia-Pacific
  • Future Regulatory Trends


Chapter 12 Competitive Landscape
  • Overview
  • Company Rankings


Chapter 13 Company Profiles
  • Abbvie Inc.
  • Amgen Inc.
  • Antares Pharma Inc.
  • Becton, Dickinson and Co.
  • Eli Lilly And Co.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck Kgaa
  • SHL Medical Ag
  • Teva Pharmaceutical Industries Ltd.
  • Ypsomed


List of Tables
Summary Table: Global Market for Autoinjectors, by Region, Through 2026
Table 1: Global Market for Autoinjectors, by Product Type, Through 2026
Table 2: Global Market for Disposable Autoinjectors, by Region, Through 2026
Table 3: Global Market for Reusable Autoinjectors, by Region, Through 2026
Table 4: Global Market for Autoinjectors, by Route of Administration, Through 2026
Table 5: Global Market for Intramuscular Autoinjectors, by Region, Through 2026
Table 6: Global Market for Subcutaneous Autoinjectors, by Region, Through 2026
Table 7: Global Market for Autoinjectors, by Therapy, Through 2026
Table 8: Global Market for Autoinjectors for Anaphylaxis Therapy, by Region, Through 2026
Table 9: Global Market for Autoinjectors for Rheumatoid Arthritis Therapy, by Region, Through 2026
Table 10: Global Market for Autoinjectors for Multiple Sclerosis Therapy, by Region, Through 2026
Table 11: Global Market for Autoinjectors for Diabetes Therapy, by Region, Through 2026
Table 12: Global Market for Autoinjectors for Other Therapies, by Region, Through 2026
Table 13: Global Market for Autoinjectors, by End User Setting, Through 2026
Table 14: Global Market for Autoinjectors Used in Home Care Settings, by Region, Through 2026
Table 15: Global Market for Autoinjectors Used in Hospitals and Clinics, by Region, Through 2026
Table 16: Global Market for Injectors Used in Ambulatory Care Settings, by Region, Through 2026
Table 17: Global Market for Autoinjectors, by Region, Through 2026
Table 18: North American Market for Autoinjectors, by Product Type, Through 2026
Table 19: North American Market for Autoinjectors, by Route of Administration, Through 2026
Table 20: North American Market for Autoinjectors, by Therapy, Through 2026
Table 21: North American Market for Autoinjectors, by End User Setting, Through 2026
Table 22: North American Market for Autoinjectors, by Country, Through 2026
Table 23: European Market for Autoinjectors, by Product Type, Through 2026
Table 24: European Market for Autoinjectors, by Route of Administration, Through 2026
Table 25: European Market for Autoinjectors, by Therapy, Through 2026
Table 26: European Market for Autoinjectors, by End User Setting, Through 2026
Table 27: European Market for Autoinjectors, by Country, Through 2026
Table 28: Asia-Pacific Market for Autoinjectors, by Product Type, Through 2026
Table 29: Asia-Pacific Market for Autoinjectors, by Route of Administration, Through 2026
Table 30: Asia-Pacific Market for Autoinjectors, by Therapy, Through 2026
Table 31: Asia-Pacific Market for Autoinjectors, by End User Setting, Through 2026
Table 32: Asia-Pacific Market for Autoinjectors, by Country, Through 2026
Table 33: Latin American Market for Autoinjectors, by Product Type, Through 2026
Table 34: Latin American Market for Autoinjectors, by Route of Administration, Through 2026
Table 35: Latin American Market for Autoinjectors, by Therapy, Through 2026
Table 36: Latin American Market for Autoinjectors, by End User Setting, Through 2026
Table 37: Middle Eastern and African Market for Autoinjectors, by Product Type, Through 2026
Table 38: Middle Eastern and African Market for Autoinjectors, by Route of Administration, Through 2026
Table 39: Middle Eastern and African Market for Autoinjectors, by Therapy, Through 2026
Table 40: Middle Eastern and African Market for Autoinjectors, by End User Setting, Through 2026
Table 41: Class I and Class II Exempt Devices
Table 42: Differences Between U.S. and European Government Regulations for Medical Devices
Table 43: Regulation in Selected Asia-Pacific Countries
Table 44: Top Five Companies in the Autoinjector Market, 2020
Table 45: Recent Developments in the Autoinjector Market, 2018 to 2021
Table 46: AbbVie: Product Portfolio
Table 47: Amgen: Product Portfolio
Table 48: Amgen: Recent Developments, 2021
Table 49: Antares Pharma: Product Portfolio
Table 50: Antares Pharma: Recent Developments
Table 51: BD: Product Portfolio
Table 52: BD: Recent Developments
Table 53: Eli Lilly: Product Portfolio
Table 54: Eli Lilly: Recent Developments
Table 55: GlaxoSmithKline PLC: Products
Table 56: GlaxoSmithKline PLC: Recent Developments
Table 57: Johnson & Johnson: Product Portfolio
Table 58: Johnson & Johnson: Recent Developments
Table 59: Merck KGaA: Product Portfolio
Table 60: SHL Medical AG: Product Portfolio
Table 61: SHL Medical Ag: Recent Developments
Table 62: Teva Pharmaceutical: Product Portfolio
Table 63: Teva Pharmaceutical: Recent Developments
Table 64: Ypsomed: Product Portfolio
Table 65: Ypsomed: Recent Developments


List of Figures
Summary Figure A: Global Market for Autoinjectors, by Region, 2019-2026
Summary Figure B: Global Market Shares for Autoinjectors, by Region, 2020
Figure 1: Global Market Share for Autoinjectors, by Product Type, 2020
Figure 2: Global Market for Autoinjectors, by Product Type, 2019-2026
Figure 3: Global Market for Disposable Autoinjectors, 2019-2026
Figure 4: Global Market for Reusable Autoinjectors, 2019-2026
Figure 5: Global Market Shares of Autoinjectors, by Route of Administration, 2020
Figure 6: Global Market for Autoinjectors, by Route of Administration, 2019-2026
Figure 7: Global Market for Intramuscular Autoinjectors, 2019-2026
Figure 8: Global Market for Subcutaneous Autoinjectors, 2019-2026
Figure 9: Global Market Shares of Autoinjectors, by Therapy, 2020
Figure 10: Global Market for Autoinjectors, by Therapy, 2019-2026
Figure 11: Global Market for Autoinjectors for Anaphylaxis Therapy, 2019-2026
Figure 12: Global Market for Autoinjectors for Rheumatoid Arthritis Therapy, 2019-2026
Figure 13: Global Market for Autoinjectors for Multiple Sclerosis Therapy, 2019-2026
Figure 14: Global Market for Autoinjectors for Diabetes Therapy, 2019-2026
Figure 15: Global Market for Autoinjectors for Other Therapies, 2019-2026
Figure 16: Global Market Shares of Autoinjectors, by End User Setting, 2020
Figure 17: Global Market for Autoinjectors Used in Home Care Settings, 2019-2026
Figure 18: Global Market for Autoinjectors Used in Home Care Settings, by Region, 2019-2026
Figure 19: Global Market for Autoinjectors Used in Hospitals and Clinics, 2019-2026
Figure 20: Global Market for Autoinjectors Used in Hospitals and Clinics, by Region, 2019-2026
Figure 21: Global Market for Autoinjectors Used in Ambulatory Care Settings, 2019-2026
Figure 22: Global Market for Autoinjectors Used in Ambulatory Care Settings, by Region, 2019-2026
Figure 23: Global Market Shares of Autoinjectors, by Region, 2020
Figure 24: North American Market Shares of Autoinjectors, by Product Type, 2020
Figure 25: North American Market Shares of Autoinjectors, by Route of Administration, 2020
Figure 26: North American Market Shares of Autoinjectors, by Therapy, 2020
Figure 27: North American Market Shares of Autoinjectors, by End User Setting, 2020
Figure 28: North American Market Shares of Autoinjectors, by Country, 2020
Figure 29: U.S. Market for Autoinjectors, 2019-2026
Figure 30: Canadian Market for Autoinjectors, 2019-2026
Figure 31: European Market Shares of Autoinjectors, by Product Type, 2020
Figure 32: European Market Shares of Autoinjectors, by Route of Administration, 2020
Figure 33: European Market Shares of Autoinjectors, by Therapy, 2020
Figure 34: European Market Shares of Autoinjectors, by End User Setting, 2020
Figure 35: European Market Shares of Autoinjectors, by Country, 2020
Figure 36: German Market for Autoinjectors, 2019-2026
Figure 37: U.K. Market for Autoinjectors, 2019-2026
Figure 38: French Market for Autoinjectors, 2019-2026
Figure 39: Italian Market for Autoinjectors, 2019-2026
Figure 40: Spanish Market for Autoinjectors, 2019-2026
Figure 41: Rest of European Market for Autoinjectors, 2019-2026
Figure 42: Asia-Pacific Market Shares of Autoinjectors, by Product Type, 2020
Figure 43: Asia-Pacific Market Shares of Autoinjectors, by Route of Administration, 2020
Figure 44: Asia-Pacific Market Shares of Autoinjectors, by Therapy, 2020
Figure 45: Asia-Pacific Market Shares of Autoinjectors, by End User Setting, 2020
Figure 46: Asia-Pacific Market Shares of Autoinjectors, by Country, 2020
Figure 47: Chinese Market for Autoinjectors, 2019-2026
Figure 48: Japanese Market for Autoinjectors, 2019-2026
Figure 49: India’s Market for Autoinjectors, 2019-2026
Figure 50: Rest of Asia-Pacific Market for Autoinjectors, 2019-2026
Figure 51: Latin American Market Shares of Autoinjectors, by Product Type, 2020
Figure 52: Latin American Market Shares of Autoinjectors, by Route of Administration, 2020
Figure 53: Latin American Market Shares of Autoinjectors, by Therapy, 2020
Figure 54: Latin American Market Shares of Autoinjectors, by End User Setting, 2020
Figure 55: Middle Eastern and African Market Shares of Autoinjectors, by Product Type, 2020
Figure 56: Middle Eastern and African Market Shares of Autoinjectors, by Route of Administration, 2020
Figure 57: Middle Eastern and African Market Shares of Autoinjectors, by Therapy, 2020
Figure 58: Middle Eastern and African Market Shares of Autoinjectors, by End User Setting, 2020
Figure 59: Marketing a Medical Device in the U.S.
Figure 60: AbbVie: Annual Revenue, 2016-2020
Figure 61: AbbVie: Revenue Share, by Region, 2020
Figure 62: AbbVie: Revenue Share, by Business Unit, 2020
Figure 63: Amgen: Annual Revenue, 2018-2020
Figure 64: Amgen: Revenue Share, by Region, 2020
Figure 65: Antares Pharma: Annual Revenue, 2018-2020
Figure 66: Antares Pharma: Revenue Share, by Region, 2020
Figure 67: BD: Annual Revenue, 2018-2020
Figure 68: BD: Revenue Share, by Region, 2020
Figure 69: BD: Revenue Share, by Business Segment, 2020
Figure 70: Eli Lilly: Annual Revenue, 2017-2020
Figure 71: Eli Lilly: Revenue Share, by Regin, 2020
Figure 72: Eli Lilly: Revenue Share, by Segment, 2020
Figure 73: GlaxoSmithKline PLC: Annual Revenue, 2017-2020
Figure 74: GlaxoSmithKline PLC: Revenue Share, by Business Segment, 2020
Figure 75: GlaxoSmithKline PLC: Revenue Share, by Region, 2020
Figure 76: Johnson & Johnson: Annual Revenue, 2016-2019
Figure 77: Johnson & Johnson: Revenue Share, by Region, 2019
Figure 78: Johnson & Johnson: Revenue Share, by Business Unit, 2019
Figure 79: Merck KGaA: Annual Revenue, 2019-2020
Figure 80: Merck KGaA: Revenue Share, by Region, 2020
Figure 81: Merck KGaA: Revenue Share, by Business Segment, 2020
Figure 82: Teva Pharmaceutical: Annual Revenue, 2017-2020
Figure 83: Ypsomed: Annual Revenue, 2018-2020
Note: Product cover images may vary from those shown

Loading
LOADING...

FEATURED COMPANIES

  • Abbvie Inc.
  • Amgen Inc.
  • Antares Pharma Inc.
  • Becton, Dickinson and Co.
  • Eli Lilly And Co.
  • GlaxoSmithKline Plc

The growing prevalence of targeted therapies, rising incidence of anaphylaxis, and the increasing number of regulatory approvals are factors responsible for this market growth.


Autoinjectors are pen-like devices used to deliver a fixed dose of a drug to a patient and are intended for self-administration. Autoinjectors are gradually becoming the gold standard in the treatment of indications such as anaphylaxis, multiple sclerosis and rheumatoid arthritis. Most of the auto-injectors are spring-loaded, and the self-injection procedure is relatively simple. These instruments can help avoid needle stick injuries and reduce needle phobia in patients. Autoinjector manufacturers are focusing on user-centric approaches to enhance ease of use and overcome the anxiety associated with self-administration of intramuscular injections.


Autoinjectors are expected to present major opportunities to investors due to the high demand in biologics development. Because the procedure does not require a visit to a hospital or clinic, it reduces dependency on healthcare professionals. Increasing adoption of auto-injectors due to benefits such as increased safety, accuracy and minimal discomfort is expected to fuel market revenue growth over the forecast period.


Note: Product cover images may vary from those shown
  • Abbvie Inc.
  • Amgen Inc.
  • Antares Pharma Inc.
  • Becton, Dickinson and Co.
  • Eli Lilly And Co.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck Kgaa
  • SHL Medical Ag
  • Teva Pharmaceutical Industries Ltd.
  • Ypsomed
Note: Product cover images may vary from those shown